Data / Drug companies / Nadolol
Nadolol: 17 companies and 53 products in the FDA NDC directory
Nadolol is listed in the FDA National Drug Code Directory by 17 companies, with 53 products in commercial distribution. 53 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on May 18, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 53
- Generic (ANDA) products
- 53 (100.0%)
- Application numbers
- 7
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list nadolol
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| BluePoint Laboratories | 9 | tablet | Generic drugs (ANDA) | February 25, 2026 |
| Alembic Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | June 8, 2023 |
| Alembic Pharmaceuticals Limited | 3 | tablet | Generic drugs (ANDA) | June 8, 2023 |
| American Health Packaging | 3 | tablet | Generic drugs (ANDA) | October 9, 2025 |
| Amneal Pharmaceuticals NY LLC | 3 | tablet | Generic drugs (ANDA) | June 2, 2017 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | June 7, 2022 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | July 26, 2019 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | June 8, 2023 |
| Cipla USA Inc. | 3 | tablet | Generic drugs (ANDA) | February 23, 2016 |
| Exelan Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | July 27, 2020 |
| Golden State Medical Supply, Inc. | 3 | tablet | Generic drugs (ANDA) | July 23, 2018 |
| Unichem Pharmaceuticals (USA), Inc. | 3 | tablet | Generic drugs (ANDA) | July 26, 2019 |
| Vgyaan Pharmaceuticals LLC | 3 | tablet | Generic drugs (ANDA) | June 30, 2020 |
| Zydus Lifesciences Limited | 3 | tablet | Generic drugs (ANDA) | August 8, 2017 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet | Generic drugs (ANDA) | August 8, 2017 |
| A-S Medication Solutions | 1 | tablet | Generic drugs (ANDA) | June 2, 2017 |
| Remedyrepack Inc. | 1 | tablet | Generic drugs (ANDA) | May 18, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 53 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 53 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| beta-Adrenergic Blocker | 53 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.